Corrigendum to "Prognostic and predictive value of CA 19-9 in locally advanced pancreatic cancer treated with multiagent induction chemotherapy: results from a prospective, multicenter phase II trial (NEOLAP-AIO-PAK-0113)": [ESMO Open 7 (2024) 100552]

I Hartlapp; D Valta-Seufzer; J T Siveke; H Algül; E Goekkurt; G Siegler; U M Martens; D Waldschmidt; U Pelzer; M Fuchs; F Kullmann; S Boeck; T J Ettrich; S Held; R Keller; F Anger; C T Germer; A Stang; B Kimmel; V Heinemann; V Kunzmann; German Pancreatic Cancer Group (AIO-PAK) and NEOLAP investigators

doi:10.1016/j.esmoop.2024.103463

Corrigendum to "Prognostic and predictive value of CA 19-9 in locally advanced pancreatic cancer treated with multiagent induction chemotherapy: results from a prospective, multicenter phase II trial (NEOLAP-AIO-PAK-0113)": [ESMO Open 7 (2024) 100552]

ESMO Open. 2024 May;9(5):103463. doi: 10.1016/j.esmoop.2024.103463. Epub 2024 May 3.

Authors

I Hartlapp¹, D Valta-Seufzer¹, J T Siveke², H Algül³, E Goekkurt⁴, G Siegler⁵, U M Martens⁶, D Waldschmidt⁷, U Pelzer⁸, M Fuchs⁹, F Kullmann¹⁰, S Boeck¹¹, T J Ettrich¹², S Held¹³, R Keller¹⁴, F Anger¹⁵, C T Germer¹⁵, A Stang¹⁶, B Kimmel¹, V Heinemann¹¹, V Kunzmann¹⁷; German Pancreatic Cancer Group (AIO-PAK) and NEOLAP investigators

Affiliations

¹ Department of Internal Medicine II, Medical Oncology and Comprehensive Cancer Center Mainfranken, University Hospital Würzburg, Würzburg.
² Department of Medical Oncology, Bridge Institute of Experimental Tumor Therapy, University Medicine Essen, Essen; Division of Solid Tumor Translational Oncology (DKTK Partner Site Essen, DKFZ Heidelberg), West German Cancer Center, University Medicine Essen, Essen.
³ Comprehensive Cancer Center München, Klinikum rechts der Isar, Technical University of Munich, School of Medicine and Health, Munich, Bavaria, Germany.
⁴ Hämatologisch-Onkologische Praxis Eppendorf (HOPE), Hamburg and University Cancer Center Hamburg (UCCH), Hamburg, Germany.
⁵ Department of Internal Medicine 5, Hematology and Medical Oncology, Paracelsus Medical University, Nürnberg.
⁶ Department of Internal Medicine III, SLK-Clinics Heilbronn GmbH, Heilbronn.
⁷ Department of Gastroenterology and Hepatology, University Hospital Cologne, Cologne.
⁸ Division of Oncology and Hematology, Charité Campus Mitte, Charité - Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin.
⁹ Clinic for Gastroenterology, Hepatology and GI-Oncology, München Klinik Bogenhausen, Munich.
¹⁰ Department of Internal Medicine I, Kliniken Nordoberpfalz AG, Klinikum Weiden, Weiden.
¹¹ Department of Medical Oncology and Comprehensive Cancer Center, Ludwig Maximilians University-Grosshadern, Munich.
¹² Department of Internal Medicine I, Ulm University Hospital, Ulm.
¹³ Department of Biometrics, ClinAssess GmbH, Leverkusen.
¹⁴ Clinical Research, AIO Studien gGmbH, Berlin.
¹⁵ Department of General, Visceral, Transplantation, Vascular and Pediatric Surgery and Comprehensive Cancer Center Mainfranken Würzburg, University Hospital Würzburg, Würzburg.
¹⁶ Department of Haematology, Oncology and Palliative Care Medicine, Asklepios Hospital Barmbek, Hamburg, Germany.
¹⁷ Department of Internal Medicine II, Medical Oncology and Comprehensive Cancer Center Mainfranken, University Hospital Würzburg, Würzburg. Electronic address: [email protected].

No abstract available

Publication types

Published Erratum